In contrast, CD38, whose expression on myeloid cells predicts favourable prognosis hence its anti-tumoural activity in HCC25 and proinflammatory cytokine TNF, were both reduced in S2 and S3 tumours (Fig. 3c). This evidence concerns the gene TNF and neoplasm.